Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,065 | 27,884 | 46,506 | 11,065 | 47,782 |
| Marketable Securities | 82,979 | 126,598 | 121,782 | 216,275 | 207,261 |
| Receivables | 3,503 | 4,682 | 5,778 | 13,087 | 6,877 |
| Inventories | 7,547 | 8,914 | 12,229 | 8,581 | 5,205 |
| TOTAL | $118,369 | $171,684 | $190,194 | $252,266 | $270,433 |
| Non-Current Assets | |||||
| PPE Net | 17,531 | 19,707 | 23,513 | 23,725 | 7,681 |
| Investments And Advances | 52,570 | 35,781 | 42,938 | 0 | 0 |
| Intangibles | 650 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13,387 | 12,298 | 11,629 | 10,662 | 6,006 |
| TOTAL | $84,138 | $67,786 | $78,080 | $34,387 | $13,687 |
| Total Assets | $202,507 | $239,470 | $268,274 | $286,653 | $284,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,401 | 1,358 | 743 | 292 | 1,820 |
| Accrued Expenses | 7,812 | 8,302 | 11,269 | 8,265 | 6,524 |
| TOTAL | $14,267 | $15,775 | $17,855 | $15,427 | $15,618 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,598 | 5,251 | 5,069 | 6,713 | 6,747 |
| Other Non-Current Liabilities | 16,750 | 17,444 | 18,252 | 17,258 | 5,605 |
| TOTAL | $16,750 | $17,444 | $18,252 | $17,258 | $5,605 |
| Total Liabilities | $31,017 | $33,219 | $36,107 | $32,685 | $21,223 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,861 | 106,028 | 104,129 | 102,905 | 101,540 |
| Common Shares | 1,068 | 1,057 | 1,040 | 1,024 | 1,012 |
| Retained earnings | -261,483 | -216,853 | -175,798 | -137,875 | -114,305 |
| TOTAL | $171,490 | $206,251 | $232,167 | $253,968 | $262,897 |
| Total Liabilities And Equity | $202,507 | $239,470 | $268,274 | $286,653 | $284,120 |